A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout
Authors:
- Wako UranoWUWako Urano
- Mariko YamanakaMYMariko Yamanaka
- Hisashi YamanakaHYHisashi Yamanaka
- Makoto HosoyamadaMHMakoto Hosoyamada
- Hitoshi EndouHEHitoshi Endou
Open Access
- 29 July 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (8) , 2576-2577
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A high prevalence of renal hypouricemia caused by inactive SLC22A12 in JapaneseKidney International, 2004
- Large-Scale Single-Nucleotide Polymorphism (SNP) and Haplotype Analyses, Using Dense SNP Maps, of 199 Drug-Related Genes in 752 Subjects: the Analysis of the Association between Uncommon SNPs within Haplotype Blocks and the Haplotypes Constructed with Haplotype-Tagging SNPsThe American Journal of Human Genetics, 2004
- The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemiaPediatric Nephrology, 2004
- Clinical and Molecular Analysis of Patients with Renal Hypouricemia in Japan-Influence of URAT1 Gene on Urinary Urate ExcretionJournal of the American Society of Nephrology, 2004
- Gateway to a long life?Nature, 2002
- Molecular identification of a renal urate–anion exchanger that regulates blood urate levelsNature, 2002
- Two independent mutational events in the loss of urate oxidase during hominoid evolutionJournal of Molecular Evolution, 1992
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences, 1981
- Preliminary criteria for the classification of the acute arthritis of primary goutArthritis & Rheumatism, 1977